Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTR.L Regulatory News (WTR)

  • There is currently no data for WTR

Interim Management Statement

3 Feb 2016 12:21

RNS Number : 9630N
World Trust Fund (The)
03 February 2016
 

The World Trust Fund

Interim Management Statement

 for the quarter ended 31st December 2015

 

The World Trust Fund (the "Fund") is publishing this Interim Management Statement in accordance with the Luxembourg law of 11 January 2008 on Transparency requirements (the "Transparency law").

 

This Interim Management Statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the Transparency law. It should not be relied upon by any other party or for any other purpose.

 

This Interim Management Statement relates to the period from 1 October 2015 to 31 December 2015 and contains information that covers this period and the period up to the date of publication of this Interim Management Statement.

 

The Fund aims to achieve long-term capital appreciation by investing in companies, in the main closed-end investment companies, whose shares trade at a discount to their underlying net asset value and are listed on international exchanges. For hedging purposes the Fund may also sell short stock indices, stocks, and shares of exchange-traded funds or closed-end funds, not exceeding 100% of the Fund's net assets.

 

Highlights:

Over the 3 month period from 1 October 2015 to 31 December 2015:

 

· The Fund's diluted net asset value (NAV) rose 7.5% to $4.376 in US$ terms (base currency), compared with a rise of 5.0% in the MSCI All Countries World Index.

· The Fund's share price rose in Sterling terms by 8.9% to 252 pence.

· The discount to NAV (in Sterling) at the end of the period was -15.1%.

· The Fund's underlying holdings had an average weighted discount of -22.5%.

 

 

Long Term Performance:

 

1-Year

3-Year**

5-Year**

10-Year**

Share Price £

+3.8%

+9.1%

+5.1%

+1.7%

Share Price US$*

-1.8%

+5.6%

+4.0%

+0.2%

Net Asset Value £*

+6.6%

+11.0%

+6.5%

+2.6%

Net Asset Value US$

+0.7%

+7.5%

+5.3%

+1.0%

MSCI All Countries World US$

-2.4%

+7.7%

+6.1%

+4.8%

MSCI AC World Ex USA

-5.7%

+1.5%

+1.1%

+2.9%

 

The MSCI All Countries World index is shown solely for the purpose of performance comparison, and in no way reflects the composition of the portfolio.

*Converted using Foreign Exchange rate used by the administrator.

** Annualized.

Top Five Holdings (%):

31/12/15

30/09/15

BB Biotech

7.2%

6.9%

Eurazeo

5.7%

5.8%

JPMorgan European Smaller Companies

5.4%

5.0%

General American Investors

5.4%

5.7%

Investor AB

4.7%

4.7%

 

 

 

 

 

Top 5 Regional Breakdown (%)

31/12/15

30/09/15

North America

23.0%

29.2%

Asia (ex-Japan)

25.1%

27.6%

Europe (ex-UK)

21.2%

21.6%

United Kingdom

10.8%

9.6%

Japan

9.5%

9.2%

 

 

31/12/15

30/09/15

Long Exposure

98.8%

101.0%

Short Exposure

0%

0.0%

Net Exposure

98.8%

101.0%

 

 

Top 10 Country Weightings (%)

 

31/12/15

United States

22.7

China

12.9

United Kingdom

10.8

Japan

9.5

France

5.7

Sweden

4.8

Switzerland

3.8

India

2.9

Philippines

2.3

Hong Kong

2.0

 

 

Leverage:

As at 31 December 2015 the Fund had no leverage.

 

Material Transactions and Events:

 

Since the period end the Fund paid a dividend of 1.0p per share on 15 January 2016 to its shareholders who appeared on its register on 18 December 2015.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFLFFTIVIIR
Date   Source Headline
11th May 201811:57 amBUSNet Asset Value(s)
9th May 201812:06 pmBUSNet Asset Value(s)
8th May 201812:02 pmBUSNet Asset Value(s)
8th May 201812:00 pmBUSNet Asset Value(s)
4th May 20183:55 pmRNSHolding(s) in Company
4th May 201812:08 pmBUSNet Asset Value(s)
3rd May 20181:33 pmRNSHolding(s) in Company
3rd May 20181:29 pmRNSMarch 2018 Fact Sheet
3rd May 201812:11 pmBUSNet Asset Value(s)
2nd May 20185:50 pmBUSNet Asset Value(s)
2nd May 201812:11 pmBUSNet Asset Value(s)
30th Apr 201811:29 amBUSNet Asset Value(s)
27th Apr 201811:15 amBUSNet Asset Value(s)
27th Apr 20187:00 amRNSRevised Dividend Policy and Dividend Declaration
26th Apr 201810:36 amBUSNet Asset Value(s)
25th Apr 201810:44 amBUSNet Asset Value(s)
24th Apr 201811:07 amBUSNet Asset Value(s)
24th Apr 201811:00 amRNSKepler Trust Intelligence: New Research
23rd Apr 201811:39 amBUSNet Asset Value(s)
20th Apr 201811:35 amBUSNet Asset Value(s)
19th Apr 201811:19 amBUSNet Asset Value(s)
18th Apr 201811:20 amBUSNet Asset Value(s)
17th Apr 201811:35 amBUSNet Asset Value(s)
16th Apr 201811:19 amBUSNet Asset Value(s)
13th Apr 20183:32 pmRNSHolding(s) in Company
13th Apr 201810:38 amBUSNet Asset Value(s)
12th Apr 201811:33 amBUSNet Asset Value(s)
11th Apr 201812:08 pmBUSNet Asset Value(s)
10th Apr 201811:48 amBUSNet Asset Value(s)
10th Apr 201811:14 amRNSFebruary 2018 Fact Sheet
10th Apr 201810:16 amRNSHoldings in Other Investment Companies
9th Apr 201812:01 pmBUSNet Asset Value(s)
6th Apr 201811:42 amBUSNet Asset Value(s)
5th Apr 201812:14 pmBUSNet Asset Value(s)
4th Apr 201811:57 amBUSNet Asset Value(s)
3rd Apr 20186:22 pmBUSNet Asset Value(s)
3rd Apr 201812:31 pmBUSNet Asset Value(s)
29th Mar 201811:31 amBUSNet Asset Value(s)
28th Mar 201811:52 amBUSNet Asset Value(s)
27th Mar 201812:24 pmBUSNet Asset Value(s)
26th Mar 201811:10 amBUSNet Asset Value(s)
23rd Mar 201812:20 pmBUSNet Asset Value(s)
22nd Mar 201811:03 amBUSNet Asset Value(s)
21st Mar 20185:30 pmRNSHolding(s) in Company
21st Mar 201811:38 amBUSNet Asset Value(s)
20th Mar 201811:28 amBUSNet Asset Value(s)
19th Mar 201810:32 amBUSNet Asset Value(s)
16th Mar 201811:56 amBUSNet Asset Value(s)
15th Mar 201812:17 pmBUSNet Asset Value(s)
14th Mar 201811:19 amBUSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.